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Abstract
n-3 PUFA are lipids that play crucial roles in immune-regulation, cardio-protection and neurodevelopment. However, little is known about the
role that these essential dietary fats play in modulating caecal microbiota composition and the subsequent production of functional
metabolites. To investigate this, female C57BL/6 mice were assigned to one of three diets (control (CON), n-3 supplemented (n3+) or n-3
deficient (n3−)) during gestation, following which their male offspring were continued on the same diets for 12 weeks. Caecal content of
mothers and offspring were collected for 16S sequencing and metabolic phenotyping. n3− male offspring displayed significantly less % fat
mass than n3+ and CON. n-3 Status also induced a number of changes to gut microbiota composition such that n3− offspring had greater
abundance of Tenericutes, Anaeroplasma and Coriobacteriaceae. Metabolomics analysis revealed an increase in caecal metabolites involved
in energy metabolism in n3+ including α-ketoglutaric acid, malic acid and fumaric acid. n3− animals displayed significantly reduced acetate,
butyrate and total caecal SCFA production. These results demonstrate that dietary n-3 PUFA regulate gut microbiota homoeostasis whereby
n-3 deficiency may induce a state of disturbance. Further studies are warranted to examine whether these microbial and metabolic
disturbances are causally related to changes in metabolic health outcomes.
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The gut microbiota is a virtual ‘organ’ referring collectively to all
of the micro-organisms residing in the gastrointestinal tract. In
recent times, much research has indicated the essentiality of this
microbial biomass for human health from birth to old age owing
to the role it plays in host immunity and metabolic health(1,2).
Furthermore, disruption to the composition and function of
the gut microbiota has been associated with a wide range of
physiological and even mental health disorders(3,4). Owing to
the ‘flexible’ nature of the gut microbiota, it is highly susceptible
to change by a number of environmental stressors to the host
including infection, medication use, stress, birth mode and
diet(5). Alongside increasing incidence of Caesarian section
births, antibiotic use and stress, the Western lifestyle is uniquely
characterised by a diet rich in fat and refined sugar and low in
fibre. The metabolic outcomes of this modernised diet have
been well characterised; however, the rates of obesity, diabetes
and chronic metabolic disease have continued to increase(6).
Expanding knowledge of the role of the gut microbiota in
such disorders indicates the potential for this microbial
‘organ’ as a new mechanism and target by which nutritional
interventions may prevent onset of diet-related metabolic
disorders. Therefore, it is essential to understand how nutri-
tional deficiencies affect gut microbiota composition and
conversely how nutritional interventions can restore normal
composition and function.
Despite much evidence pointing to the role of excess sugar
and SFA intake in the epidemic of diet-induced metabolic dis-
ease, one of the most drastic changes in the Western diet over
the past five decades has been the intake of n-3 PUFA relative
to n-6 PUFA(7). It is widely acknowledged that humans evolved
on an n-6:n-3 PUFA ratio of about 1–2:1; however, the modern
diet, which is high in n-6 PUFA-rich vegetable oils, has
contributed to a modern n-6:n-3 PUFA ratio of 20–30:1(7). This
drastic increase in n-6 PUFA, combined with declining n-3
Abbreviations: CON, control; FAME, fatty acid methyl esters; n3+, n-3 supplemented; n3 − , n-3 deficient; TCA, tricarboxylic acid.
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PUFA intake, which are found in oily fish, nuts and seeds, has
contributed to relative n-3 deficiency, which has likely spanned
two to three generations since the 1970s(8). n-3 Deficiency has
hence been associated with progression of a number of chronic
metabolic disorders. Maternal nutritional deficiencies have also
been proven to increase offspring disease risk in later life, as
shown by the Barker hypothesis(9). Hence, it is possible that
trans-generational nutritional inadequacies, such as n-3 PUFA
deficiency, across two to three generations may further
compound the effects on later life disease risk.
Growing evidence suggests a potential role of a disrupted
microbiota in metabolic disorders induced by n-3 PUFA
deficiency. For example, high n-6 dietary intake induces gut
microbiota dysbiosis resulting in increased intestinal perme-
ability, metabolic dysfunction and adipose tissue inflammation,
which is reversed by n-3 feeding(10). Similarly, using a germ-
free model, Caesar et al.(11) have shown that a diet containing
fish oil, rich in n-3 PUFA, reverses adipose tissue inflammation
through toll-like receptor signalling, which is mediated through
comprehensive changes in gut microbiota composition.
Similarly, it has been suggested that the beneficial effects of n-3
fatty acids on metabolic endotoxaemia are mediated through
increased production of the lipopolysaccharide (LPS)-scavenging
antimicrobial peptide intestinal alkaline phosphatase (IAP)(12).
Indeed, the effects of n-3 and n-6 PUFA on the adult
microbiota composition have recently been investigated in
animals(13–16). However, less data are available on the role of
maternal and early-life n-3 deficiency on the development of
microbiota from birth, which may reflect current human dietary
trends(17). Murine models are particularly suitable for assessing
dietary interactions with the microbiota trans-generationally and
throughout the lifespan. Gibson et al.(18) reported that maternal
fish oil supplementation in pharmacological excess (18%
energy) led to the overgrowth of opportunistic pathogens such
as Bilophila wadsworthia and Enterococcus faecium in off-
spring microbiota and alteration of macrophage homoeostasis.
Similarly, it has been shown that parental n-3 PUFA intake
altered offspring gut microbiota composition in mice and
dampened the immune response(19). These studies, however,
provided n-3 PUFA in pharmacologically excessive doses,
which may not reflect normal dietary intake, and in addition
did not examine the progression of microbiota development
into adulthood.
Furthermore, the subsequent effect of dietary lipids on the
metabolic phenotype remains underreported. Recently, Daniel
et al.(20) provided a comprehensive report of the caecal meta-
bolomic alterations induced by a high-fat diet in mice, which
provided novel insights into the functional metabolic changes
induced by high-fat-diet-induced microbiota. The effect of n-3
PUFA on liver metabolite production has also previously been
outlined(21). However, there is a lack of data available of the
effects of n-3 PUFA on the caecal metabolic phenotype and the
functional effects this may have on host physiology.
We have previously shown that varying n-3 availability
differentially alters the composition of the faecal microbiota at
both adolescence and adulthood(14). However, it has been
shown that differences may exist in the microbiota composition
of different intestinal regions(22). The caecum, as the region of
the intestine with the densest population of bacteria, acts as the
primary site of microbial–nutrient interaction. This interaction
may mediate production of bacterial metabolites such as SCFA,
which can regulate various aspects of metabolic health. Hence,
the effects of varying n-3 availability on the caecal microbiota
may differ from those of the faecal microbiota and may
additionally influence the caecal metabolome.
Here, we hypothesised that varying n-3 availability
throughout life may differentially alter the caecal microbiota
and that n-3 deficiency may induce a state of compositional and
functional disturbance. This study aimed to address both: (i) the
lack of knowledge about biologically relevant intakes of n-3 on
the microbiota and (ii) the trans-generational effect of n-3
deficiency on the caecal microbiota, reflective of the long-term
deficiency of n-3 in the Western diet. Hence, we investigated
the impact of n-3 deficiency and n-3 supplementation in mice
on the caecal microbiota composition of mothers and their male
offspring. In addition, we sought to examine changes to the
caecal metabolic phenotype induced by varying n-3 availability.
Methods
Animals
Male and female C57BL/6J mice, eight-week old, were
purchased from Harlan Laboratories, UK. Animals were kept in
the University College Cork animal facility on a 12 h light–12 h
dark cycle at 20± 1°C. After acclimatisation, female and male
breeding pairs were combined and assigned to one of three
diets: – control (CON), n-3-supplemented (n3+) diet and
n-3-deficient (n3−) diet – from gestational day 0. Male offspring
(n 10/group) were randomised within treatment groups, group-
housed (3–4/cage) and weaned on to the same diets
as their mothers.
Food intake and body weight were recorded weekly during
12 weeks of dietary treatment. Fat and lean body mass were
measured using a Minispec mq bench-top NMR spectrometer
(Bruker Instruments) before euthanasia. The welfare and gen-
eral health status of the animals were continuously monitored
throughout the experimental period. No adverse events were
observed. All experiments were conducted in accordance with
the Directive 2010/63/EU and were approved by the Animal
Experimentation Ethics Committee of University College Cork
no. 2012/036.
Diets
Dietary intervention was provided to mothers during gestation
and lactation and continued in the offspring through until
adulthood. The three dietary treatments were matched for
macronutrient content and differed only in fatty acid profile, as
follows: (1) control standard chow (CON); (2) n-3 PUFA-
supplemented diet (n3+)− 1 g EPA+DHA/100 g diet; (3) n-3
PUFA-deficient diet (n3−) (Table 1, online Supplementary
Tables S1 and S2). The n3+ diet was prepared with microalgal
oil rich in EPA/DHA (life’sOmegaTM45; DSM). Diets were for-
mulated and supplied by Harlan Laboratories, Inc., which were
matched for macronutrient content and differed only in fatty
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acid profile. The detailed compositions and fatty acid profiles of
the three diets have previously been reported(14). In order to
limit the oxidation of long-chain fatty acids, diets were kept
at 4°C in the dark and in vaccum packaging. Once placed in
animal cages, the diets were changed twice per week.
Experimental design
Fig. 1(a) illustrates the experimental design. In brief, C57BL/6J
females were assigned one of the three diets at gestational day
0. Upon confirmation of pregnancy, males were removed and
the pregnant dams were continued on the dietary treatment for
6 weeks, during pregnancy and lactation. Male offspring were
subsequently weaned onto the same diets as their mothers until
adulthood (12 weeks). Mothers were euthanised at weaning
(week 4). At 12 weeks old, offspring were euthanised by
decapitation and samples collected.
Tissue harvesting
Mice were euthanised by decapitation and trunk blood was
collected in potassium EDTA tubes. Plasma was prepared by
collecting supernatant following centrifugation of blood sam-
ples for 15min at 8000 g. The erythrocyte pellet was washed
three times with a 5-fold volume of PBS and centrifuged at
1000 g for 5min before fatty acid analysis. Dissected tissues
were weighed, snap-frozen in liquid N2 and stored at −80°C
until further analysis.
Tissue fatty acid analysis
Fatty acid analysis was performed on epididymal fat, ery-
throcyte and liver tissues. In brief, lipid extraction was per-
formed using chloroform–methanol (2:1, v/v) as previously
described(23). Methylation of lipid extracts was performed using
10ml of 0·5N NaOH in methanol and heating at 90°C for
10min, followed by the addition of 10ml of 14% BF3 in
methanol for 10min at 90°C(24). Fatty acid methyl esters (FAME)
were resuspended in hexane and analysed by GC.
Separation of FAME was performed via GC (Agilent 7890B;
Agilent Technologies) with flame ionisation detection
(100m× 0·25mm internal diameter, 0·25 μm film thickness,
Chrompack CP Sil 88 column, Chrompack; JVA Analytical)
and He as a carrier gas. The GC column oven cycle was
programmed as follows: 80°C for 8min followed by an increase
by 8·5°C/min to a final column temperature of 200°C. Sample
injection (0·5 μl) was automated (CTC Autosampler, Model 80)
on an Aglient Multimode Inlet on-column temperature pro-
grammable injector (Agilent). Peak integration was performed
using the Agilent OpenLAB Chemstation software (version
A.01.06.111). Identification of individual FAME was done by
comparison of retention times with pure FAME standards (Nu-
Chek-Prep). Results are expressed as g/100 g total FAME.
DNA extraction and 16S sequencing
Total bacterial metagenomic DNA was extracted from the caecal
content of mothers following euthanasia after 6 weeks of dietary
treatment. DNA from the caecal content of offspring was also
extracted after euthanasia after 12 weeks. DNA was extracted
using a commercial DNA extraction kit (QIAmp DNA Stool Mini
Kit; Qiagen). An initial repeated bead beating step was per-
formed before DNA extraction in order to increase final DNA
yield. DNA quantification was performed using a Nanodrop 1000
(Thermo Scientific) and stored at −20°C until analysis.
16S MiSeq sequencing was performed using the 16S metage-
nomic sequencing library protocol (Illumina), as previously
described(25). The V3–V4 variable region of the 16S rRNA gene
was amplified from the DNA using two PCR reactions and clean-
up steps. The initial PCR reaction used primers specific for
amplification of the V3–V4 region of the 16S rRNA gene (forward
primer 5' TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGC
CTACGGGNGGCWGCAG; reverse primer 5' GTCTCGTGGG
CTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAA
TCC). Confirmation of PCR product size was performed by
visualisation on an agarose gel via gel electrophoresis. PCR pro-
duct clean-up and purification was achieved using AMPure XP
magnetic beads (Labplan). The second PCR reaction was subse-
quently performed to index and barcode individual samples in
order for samples to be pooled and sequenced together in one
flow cell. Samples were demultiplexed for analysis after sequen-
cing. A unique indexing primer pair was used for each sample
(Illumina Nextera XT indexing primers; Illumina). PCR product
size was again confirmed via gel electrophoresis, and samples
were cleaned and purified a second time using AMPure. Samples
were quantified using the Qubit broad-range DNA quantification
assay kit (Bio-Sciences). Following quantification, samples were
normalised to an equal concentration (4nM) and pooled together
for analysis. The sample pool was denatured and diluted to 4pM
and MiSeq sequencing was performed according to Illumina
guidelines by the Eurofins sequencing facility (Eurofins) using a
2×300 cycle V3 kit.
Bioinformatics
A total of 300 bp paired-end reads were assembled using FLASH
with minimum and maximum overlap parameters of 20 and
Table 1. Macronutrient profiles of intervention diets
CON n3+ n3−
Protein (% by weight) 18·3 18·3 18·3
Carbohydrate (% by weight) 56·7 56·5 56·7
Fat (% by weight) 10·0 10·0 10·0
Protein (% of kJ) 18·8 18·8 18·8
Carbohydrate (% of kJ) 58·2 58·0 58·2
Fat (% of kJ) 23·1 23·2 23·1
kJ/g 16·3 16·3 16·3
LA (% by weight) 2·6 2·6 2·6
ALA (% by weight) 0·4 0·4 0
EPA (% by weight) 0 0·35 0
DHA (% by weight) 0 0·66 0
n-6 (% by weight) 2·6 2·6 2·6
n-3 (% by weight) 0·4 1·53 0
CON, control; n3+, n-3 PUFA-supplemented diet; n3−, n-3 PUFA-deficient diet; LA,
linoleic acid (C18 : 2n-6); ALA, α-linolenic acid (C18 : 3n-3); EPA, C20 : 5n-3; DHA,
C22 : 6n-3; n-6, n-6 PUFA; n-3, n-3 PUFA.
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120 bp, respectively(26). Further processing of paired-end reads,
including quality filtering based on a quality score of >25 and
removal of mismatched barcodes and sequences below length
thresholds, was performed using the QIIME suite of tools,
version 1.9.0(27). Denoising, chimera detection and operational
taxonomic unit (OTU) grouping were performed in QIIME
using USEARCH version 7(28). Taxonomic ranks were assigned
by alignment of OTU using PyNAST to the SILVA SSURef
database release 116(29). Alpha and beta diversities were
generated in QIIME and calculated based on weighted
and unweighted Unifrac distance matrices(30). Principal
coordinate analysis plots were visualised using EMPeror version
0.9.3-dev(31).
Metabolomics
Metabolomics analysis of caecal water was performed as fol-
lows. Caecal water was prepared by the addition of sterile water
to caecal content (approximately 100mg) followed by vortex
mixing. Bacteria and other solids were pelleted by centrifuga-
tion at 16 000 g for 30min. The supernatant was removed,
placed in a clean tube and centrifuged again at 16 000 g for
30min. The supernatant was centrifuged once more before
being filtered through a VectaSpin microcentrifuge 0·2-µm filter
(Sigma-Aldrich) at 10 000 g. The resulting filtrate was stored
at –20°C until analysis.
Derivatisation of caecal water samples for GC-MS was carried
out using methylchloroformate, as previously described(32) with
slight modifications. Analysis was performed using GC (Agilent
6890N) coupled with a quadropole detector (Agilent 5975B).
The system was controlled by ChemStation (Agilent
Technologies). Data were converted to netCDF format using
ChemStation, before being imported into Matlab R2014b
(Mathworks Inc.), and processed using PARAFAC2 to obtain
relative concentrations for each peak. PARAFAC2 was applied
using the PARADISe software. Samples were analysed in
randomised order.
SCFA analysis
SCFA were analysed by GC. A volume of 1ml of sterile Milli-Q
water was added to a known amount of mice caecal content
(approximately 100mg). The sample was vortexed thoroughly
and allowed to stand at room temperature for 10min. Bacteria
and other solids were pelleted by centrifugation at 10 000 g for
5min, and the supernatant was filtered into clean tubes.
An internal standard (10mM 2-ethylbutyric acid (Sigma)) was
subsequently added to each sample in duplicate. Samples were
vortex-mixed and centrifuged again at 10 000 g for 3min and
then transferred to clean vials. SCFA were analysed by GC
(Varian 3800 flame ionization) fitted with a ZB-FFAP column
(30m× 0·32mm× 0·25; Phenomenex). He was used as a carrier
gas at a flow rate of 1·3ml/min. The GC oven cycle was
programmed at 100°C for 0·5min and increased by 8°C/min to
180°C, held for 1min, and then increased by 20°C/min to a final
temperature of 200°C and held for 5min. The detector and
injector were programmed at 250 and 240°C, respectively.
Peak integration was performed using the Varian Star
Chromatography Workstation Software version 6.0. A standard
curve of SCFA standard solutions was used for comparison of
retention times and for identification and quantification of
individual sample peaks.
Statistical analysis
Parametric statistical analyses were performed using GraphPad
Prism version 6 (La Jolla). Non-parametric analyses of micro-
biota and metabolomic data were performed using SPSS version
20. Results are presented as means with their standard errors.
Significant differences between treatment groups were assessed
by one-way ANOVA followed by Tukey’s multiple comparison
post hoc test. Significant differences between non-parametric
data were assessed by Kruskal–Wallis tests followed by Mann–
Whitney test to determine differences between individual
groups. False discovery rate analysis was performed using
Benjamani–Hochberg correction testing following which sig-
nificance was calculated at q< 0·05. Owing to the multi-
dimensional nature of omics data, sample size was calculated
based on % fat mass. Using one-way ANOVA, two-sided sig-
nificance level was set at α= 0·05. Effect size was estimated
based on previous studies of maternal n-3 supplementation and
offspring fat mass(33). Using thirty animals, statistical power
was calculated at β> 0·9.
Results
Body composition and dietary intake
There were no significant differences in body weights or in
dietary intakes at weaning or euthanasia between groups
(Fig. 1(b)). At week 12, % total fat mass was significantly lower
(P= 0·0004) and % lean body mass significantly higher
(P= 0·001) in the n3− group compared with both other groups.
Fatty acid analysis
Fatty acid analysis revealed distinct differences in tissue fatty
acid profiles between groups. In epididymal fat, liver and ery-
throcytes, n-6 ARA content was significantly higher in n3−
animals and significantly lower in n3+ animals compared with
CON (online Supplementary Table S3). n-3 PUFA were not
detected in the epididymal fat or erythrocytes of n3− offspring
and contributed a minor proportion of fatty acids in the liver
(0·3%) (Fig. 1(c)). Contrastingly, in epididymal fat, liver and
erythrocytes, DHA accounted for 2·2, 17·3 and 6·5% of fatty
acids in n3+ mice, respectively, whereas in CON mice DHA
accounted for 0·1, 8 and 3·8% of total fatty acids in these tissues.
Linoleic acid was significantly lower in n3− epididymal tissue
compared with both other groups.
Composition of caecal microbiota
16s sequencing of the caecal microbiota resulted in a total of 3·1
million sequenced reads, corresponding to an average of 68 534
reads/sample. To remove any bias from variation in sample
read number, samples were rarefied to 25 000 reads.
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Whole microbiome significance testing using ADONIS with
Bray–Curtis similarity index showed no significant differences in
beta diversity between offspring treatment groups (P= 0·0925,
Fig. 2(a)). Phylogenetic alpha diversities revealed some differ-
ences between treatment groups (Fig. 2(b)). Caecal microbiota
alpha diversity was significantly lower in both n3+ and n3−
mothers compared with the CON group, as assessed by the
Shannon index; however, the n3− group also displayed
significantly lower diversity compared with the n3+ group. No
significant differences in alpha diversity were observed in any
of the offspring.
The overall phylum level distribution was similar between
mothers and their offspring (Fig. 2(c)); however, relative
abundance analysis of different taxa at phylum level revealed
some differences between treatment groups. Firmicutes and
Bacteroidetes were the most abundant phyla in each group in
both mothers and offspring. n3+ Mothers displayed greater
proportional abundance of Bacteroidetes (P= 0·032) and a
lower Firmicutes:Bacteroidetes ratio (P= 0·046). These differ-
ences were not observed in offspring; however, n3− offspring
displayed greater proportional abundance of Tenericutes
(P= 0·002) and an apparent bloom in Cyanobacteria
(P= 0·001), which was not present in other groups.
A number of significant differences were observed at family
and genus level distributions, many of which showed similar
differences between mothers and offspring (Fig. 2(d), Table S4
and S5). Relative abundance of Coriobacteria was significantly
greater in n3− offspring (P= 0·002). Similarly, Gelria and
Anaeroplasma were significantly greater in n3− offspring
compared with both other groups (P= 0·002, P= 0·014
respectively). Linear discriminate analysis (LDA) revealed
similar results (Fig. 3(a)), which are also represented in a
heatmap in Fig. 3(b). LDA effect size analysis (LEfSe) revealed
that n3− animals were defined by greater abundance of taxa
within the Cyanobacteria phyla and the Coriobacteriaceae,
Thermoanaerobacteracaeae and Anaeroplasmataceae families
(Fig. 3(c)).
Composition of caecal metabolome
Supervised modelling using principle least squares discriminant
analysis (PLS-DA) of the caecal metabolome revealed separa-
tion of the n3+ group from both n3− and CON (Fig. 4(a)). The
metabolites contributing most strongly to this separation are
plotted in a heatmap in Fig. 3(b). LEfSe analysis showed that the





















































































































































Fig. 1. n-3 deficiency and supplementation alter body composition and tissue fatty acid status. (a) The study design involved a dietary intervention with a control
(CON), n-3-supplemented (n3+) or n-3-deficient (n3−) diet in mothers throughout pregnancy. The interventions were continued in the offspring for 12 weeks. (b) There
were no significant differences in offspring body weight at weaning (week 4) or adulthood (week 12). However, at week 12, n3− caused significantly decreased fat
mass and increased lean mass compared with CON and n3+. (c) At week 12, n-3 supplementation induced significantly greater total n-3 PUFA in epididymal adipose
tissue, erythrocytes and liver, whereas n-3 PUFA were almost entirely absent in these tissues in n3− animals. Values are means (n 9–10/group), with their standard
errors represented by vertical bars. FAME, fatty acid methyl esters. CON v. n3+ or n3− group: * P< 0·05, ****P< 0·0001; n3+ v. n3−: ††† P< 0·001, †††† P< 0·0001.
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(d)
Fig. 2. Effects of n-3 PUFA on caecal gut microbiota in mothers and adult offspring (a) Principle coordinate analysis of microbiota composition. (b) n-3-deficient (n3−)
alpha diversity of mothers microbiota was significantly lower than n-3-supplemented (n3+) and control (CON) as measured by the Shannon index. (c) Phylum level
distribution of caecal microbiota. (d) A number of significant taxonomic differences were observed between groups based on n-3 status. Values are means (n 4–5/
group for mothers and 9–10/group for offspring (week 12)), with their standard errors represented by vertical bars. a: , CON; , n3+; , n3−; b: , CON; , n3 +; ,
n3− ; c: , Firmicutes; , Bacteroidetes; , Proteobacteria; , Deferribacteres; , Tenericutes; , Verrucomicrobia; , Actinobacteria;
, Candidate_division_TM7; , other; d: , CON; , n3+; , n3−. CON v. n3− or n3+ group: * P< 0·05, n3+ v. n3−: † P< 0·05. Analysis by non-parametric
Kruskal–Wallis test followed by multiple comparisons by Mann–Whitney. False discovery rate corrected using Benjamani–Hochberg testing q< 0·05. * Significantly
different from CON. † Significantly different from n3+.
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abundance of fatty acids and metabolites involved in energy
metabolism (Fig. 4(c)). Further analysis of the metabolites that
contributed to the differences between groups using non-
parametric Kruskal–Wallis testing observed that metabolites
involved in energy metabolism, notably α-ketoglutaric acid
(P= 0·014), fumaric acid (P= 0·031) and malic acid (P= 0·013),
were elevated in caecal water of n3+ animals (Fig. 4(d)).
However, following false discovery rate correction testing by
Benjamani–Hochberg analysis, these differences were no
longer significant. Full metabolomics data are available in the
online Supplementary Data Document S2.
Caecal SCFA production
Caecal SCFA production was significantly altered by diet, as
displayed in Fig 5. Overall, the n3− group displayed
significantly reduced production of total SCFA compared with
CON (P= 0·013) (Fig. 5(a)), which was driven by significant
reductions in acetate (P= 0·016) and butyrate (P= 0·009)
production. However, the n3+ group also demonstrated a
significant reduction in butyrate production compared with
CON. There were no significant differences observed between
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Fig. 3. Differential abundance of gut microbiota taxa following n-3 intervention. Linear discriminate analysis (LDA) scores of taxa significantly altered by n-3 status in
offspring are shown in (a) (LDA scores >2 and significance of P< 0·05 as determined by Wilcoxon’s signed-rank test). The most differentially abundant taxa in
adulthood following dietary intervention are represented as a cladogram in (c) as generated from LDA effect size analysis data in (a). Heatmap distribution of
differentially abundant taxa in adulthood offspring (b). n 9–10/group, offspring (week 12). Analysis by non-parametric Kruskal–Wallis test followed by multiple
comparisons by Mann–Whitney test. False discovery rate corrected using Benjamani–Hochberg testing q< 0·05. a and c: , CON; , n3+; , n3−; b: , lower
abundance; , higher abundance.
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production correlated with microbial taxa, whereby total SCFA
positively correlated with both Enterobacteriaceae (r2 0·414;
P= 0·0002) and lachnospiraceae incertae sedis (r2 0·464;
P= 0·0001) abundance (Fig. 5(b)).
Discussion
Nutritional deficiencies as seen in the Western diet may con-
tribute to modern chronic disease epidemics. The mechanisms
behind this interaction between undernutrition and metabolic
disease are slowly being elucidated, and the relative deficiency
of n-3 PUFA in the Western diet may play a role in this
pathogenic interaction. With growing evidence of the impor-
tance of the gut microbiome in human physiology and emer-
ging knowledge of nutrient–microbiota interactions, it is
plausible that a disturbed microbiome mediates the effect of
nutrient deficiency on host metabolic dysfunction. We have
shown here that n-3 PUFA supplementation alters the caecal
metabolic phenotype by up-regulating the production of energy
metabolites. However, deficiency of essential dietary n-3 PUFA
induces a state of compositional and functional disturbance to
the gut microbiome and metabolic phenotype, which may have
implications for subsequent metabolic disorders.
The mechanisms by which n-3 PUFA interact with the gut
microbiota and host metabolism are slowly being resolved(34).
It has recently been suggested that n-6 PUFA stimulate a
pro-inflammatory intestinal environment characterised by
increased gram-negative bacteria such as Enterobacteriaceae,
increased gut permeability and subsequent translocation
of LPS across the epithelial barrier(12). n-3 PUFA may resolve
this cascade of events through the stimulation of Bifidobacter-
ium growth and IAP production, an antimicrobial peptide that
scavenges LPS(12). Interestingly, this was examined in a trans-
genic model of endogenous n-3 production, suggesting that n-3
PUFA may have an indirect and direct interaction with the
commensal microbiota. Here, it was shown that n-3 deficiency
altered the composition of the murine gut microbiota compared
with control or n-3-supplemented diets. These differences
included an increase in taxa within the Tenericutes phylum,
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Fig. 4. n-3 PUFA-induced changes to the caecal metabolome. Partial least squares discrimination analysis revealed differences in the caecal metabolomic profile
between groups that were driven by changes in n3+ (a). Heatmap distribution shows the relative abundance of metabolites contributing most strongly to differences
between groups (b). Linear discriminate analysis (LDA) scores of taxa significantly altered by n-3 status in offspring are shown in (c) from data generated using LDA
effect size analysis analysis (LDA scores >2 and significance of P<0·05 as determined by Wilcoxon’s signed-rank test). The metabolites contributing most strongly to
the separation were those involved in energy metabolism (d). n 8/group, offspring (week 12). a: , CON; , n3+; , n3−; , Discrim Y 1; c: , CON; , n3+; ,
n3− . ‘?’ Signifies compounds that were identified using a database based on retention times rather than standards. Analysis by non-parametric Kruskal–Wallis test
followed by multiple comparisons by Mann–Whitney test.
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abundance. Tenericutes have previously been shown to be
elevated in high-fat-diet-fed mice and are correlated
with obesity-associated metabolic parameters(35). Similarly,
coriobacteria were elevated in obese subjects, an effect that
was normalised by gastric bypass surgery, suggesting that this
species is present as an effect or may even contribute to
metabolic disorders(36). The animals in this study, however,
were not obese and hence the observed loss in % fat mass in the
n3− mice compared with CON is noteworthy. It has previously
been shown that maternal n-3 supplementation in healthy rats
increases weight and fat mass in offspring(33). Hence, it is likely
that the anti-adipogenic properties of n-3 PUFA may only be
relevant in cases of overweight or obesity. Furthermore,
Anaeroplasma, a species within the Tenericutes phylum, was
significantly increased in mice following L-carnitine feeding.
This was associated with elevated trimethylamine-N-oxide, a
key metabolite involved in CVD progression(37). These data
may suggest that the role of n-3 PUFA status in chronic
metabolic disease can be mediated through modulation of the
gut microbiota.
The overall microbiota composition was similar between
mothers and offspring; however, it appeared that compositional
differences between groups were more evident in offspring,
which may be because of longer dietary exposure. Interestingly,
these caecal compositional data appeared to differ from
previously published faecal data from the same treatment
groups(14), suggesting that the caecal microbiota may differ
significantly from the faecal microbiota owing to altering
composition within different regions of the intestinal tract.
Segmental differences have been previously observed in the gut
microbiota(22). This is of particular note in this study as a
majority of PUFA are absorbed in the upper intestinal tract(38).
Therefore, these data suggest that a certain proportion of
dietary PUFA reach the caecum and interact directly with the
caecal microbiota differently to the lower colonic microbiota or
alternatively exert differing indirect effects on the intestinal
environments of these two regions, which modifies microbial
composition.
We further analysed the composition of the caecal metabo-
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Fig. 5. Caecal SCFA production. n3− displayed significantly reduced caecal acetate butyrate and total SCFA production. n3+ also displayed significantly reduced
butyrate production (a). Caecal SCFA abundance positively correlated with specific microbial taxa (b). Values are means (n 9–10/group, offspring (week 12)), with their
standard errors represented by vertical bars. * P<0·05 v. CON.
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composition induced by varying n-3 PUFA status resulted in
modifications to the metabolic phenotype. This is the first study
to examine the effect of n-3 PUFA supplementation or defi-
ciency on the caecal metabolome. However, previously, the
liver metabolome was assessed in the context of n-3 PUFA(21).
Indeed, the caecal metabolome has been examined in the
context of high-fat diet feeding in which there were distinct
effects on markers of fat and carbohydrate metabolism. PLS-DA
analysis of the metabolomics data suggested that differences
between groups were driven by alterations to the n3+ group,
which was primarily driven by metabolites involved in energy
metabolism namely fumaric acid, malic acid and α-ketoglutaric
acid. The microbiota has previously proven essential for energy
metabolism. Malic acid, fumaric acid and other energy meta-
bolites involved in the tricarboxylic acid (TCA) cycle were
previously shown to be significantly increased in the serum
of conventionally raised animals compared with germ-free
animals(39). Furthermore, using predicted functional metage-
nomics, it has been shown that the TCA cycle is down-regulated
on a high-fat diet, an effect that is reversed with high-intensity
exercise(40). Hence, these results may suggest that n3+ has a
beneficial effect on energy metabolism through compositional
changes in the gut microbiota and on host metabolic activity
particularly regarding the TCA cycle. These results, however,
should be interpreted with caution owing to the relative flux of
the TCA cycle in different disease states and as significant
differences exist between the caecal, serum and urinary meta-
bolomes. For example, TCA metabolites, such as those
observed here, are decreased in the urinary metabolome of the
obese Zucker rat but increased in ob/ob mice(41–43). Therefore,
no strict conclusions can be made about this effect of n3+ on
the caecal metabolome, but these novel data may provide
useful information for future studies about the role of n-3 PUFA
in host and microbial metabolism.
A more targeted analysis of caecal SCFA production revealed
that n3− significantly reduced the production of acetate, buty-
rate and total SCFA. n3+ also significantly reduced
butyrate production. SCFA are typically the fermentation
products of indigestible dietary fibres and function as the
key energy source for colonocytes(44). A number of studies
have shown their importance in the regulation of cholesterol,
glucose and lipid metabolism; therefore, impaired SCFA
production has been associated with metabolic disruption
and chronic disease progression. The observed impairment of
SCFA production in n3− suggests that such a deficiency in n-3
PUFA disrupts the homoeostatic intestinal environment, which
may have implications for metabolic disease. Indeed, certain
taxa involved in SCFA production, namely members of the
Clostridiaceae family, were not detected in n3− microbiota,
suggesting that n-3 PUFA deficiency in the diet resulted in the
absence of SCFA-producing bacteria among the gut microbiota.
However, the observed disruptions to SCFA production in
n3− were not due to differences in abundance of other
well-known butyrate producers such as Roseburia and
Pseudobutyvibrio.
Recent work has demonstrated the profound influence of
micronutrient deficiencies on the murine microbiota and
metabolic phenotype(45). Here we have similarly demonstrated
that n-3 PUFA deficiency can also influence the gastrointestinal
environment. This study is strengthened by its multi-omics
approach, which allows insight not only into the composition of
the gut microbiota but also into the functional output of both
microbial and host metabolism under different dietary condi-
tions. Such approaches are warranted in future studies in order
to deepen our understanding of host–microbial interactions.
The extent to which microbial metabolites could be identified
and quantified in this study, however, was limited by the
metabolomics techniques used, and hence further in-depth
metabolomics analysis may provide greater insight into the
microbial metabolic phenotype of n-3 deficiency or supple-
mentation. Furthermore, the translation of these results from
mice to humans is limited by the differences in microbiota
between the two species(46).
n-3 PUFA have consistently reported beneficial effects for
cardiovascular, immune and metabolic health; however, the
role they play in modulating the gut microbiota composition has
remained unclear and their role in the composition of the caecal
metabolome has not been examined previously. These results
suggest that dietary n-3 PUFA play a crucial role in structuring
gut microbiota composition and metabolic activity. Dietary n-3
deficiency appears to induce gut microbial imbalance, which
may contribute to impaired SCFA production. Conversely,
greater n-3 intake enhances production of energy metabolites
possibly through modulation of gut microbiota composition.
Further research is required to elucidate the long-term impact of
such altered microbiota and metabolomic profiles on chronic
disease progression. However, this novel information may
inform future research into microbiota-targeted nutritional
therapies for metabolic disorders.
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